Kazatomprom (KAP) — Stock Analysis 2026 [4.2]
Analysis as of 20 August 2026. This is a point-in-time snapshot, not an evergreen guide. Fundamentals are from Kazatomprom’s 2025 Integrated Annual Report and consolidated financial statements (year ended 31 December 2025) and the JORC-basis reserves and resources reported in it (effective 31 December 2025). Market data — the LSE GDR price, market capitalisation and enterprise value — is as of the 17 August 2026 close. Rating: ★★★★ (4.2/5), Solid — Modestly overvalued → the world’s largest and lowest-cost uranium producer, with net cash and a ~3.5% dividend, but the shares trade about 25% above a conservative discounted-cash-flow value struck at a Kazakhstan risk premium. Price deck (Table 3b uranium rungs): bear US$75/lb, base US$100/lb, bull US$125/lb; the long-term contract indicator (~US$86–90/lb) and spot (~US$86/lb) sit just below the base rung and carry as cross-checks. Discount rate 12% (an ~8–9% uranium-producer base plus a ~3–4% Kazakhstan country premium). All figures are US dollars. Kazatomprom reports in Kazakhstani tenge (KZT), converted here at the 2025 average of KZT 521.37/US$ for income-statement items and the 31 December 2025 close of KZT 502.57/US$ for balance-sheet items; market data converts at the current ~KZT 477/US$. Refreshed on each annual report and on material events. For information only, prepared with AI assistance — see the disclaimer at the end.
Kazatomprom mines roughly one in every four pounds of uranium produced on Earth, and it does so more cheaply than anyone else alive. The thesis in one line: the national atomic company of Kazakhstan controls ~735 million attributable pounds of reserves at a C1 cash cost near US$18/lb — less than half the cost of any Western peer — carries net cash and pays out most of its free cash flow as a dividend, yet trades about 25% above a discounted-cash-flow value struck at the risk premium its single-country, state-controlled structure deserves. Why look now: the company is guiding production up ~10% in 2026 into a term uranium market that has held near US$86–90/lb, the highest since 2008, while a new Mineral Extraction Tax and December 2025 amendments to Kazakhstan’s Subsoil Code are quietly changing the fiscal and control backdrop the whole thesis rests on. To screen Kazatomprom against every listed uranium name on reserves, cost and production, go to Metal Pilot.
1. Snapshot & thesis
National Atomic Company Kazatomprom JSC (LSE: KAP; AIX: KAP) is the world’s largest uranium producer — a state-controlled in-situ recovery (ISR) miner headquartered in Astana, Kazakhstan, that produced roughly 23% of global primary uranium in 2025. By archetype it is a producer/operator (mining), so the full nine-dimension rubric applies (Section 9) and the valuation runs a net-asset-value discounted cash flow plus cash-flow multiples (Section 7). It operates through fourteen mining subsidiaries and joint ventures across the Chu-Sarysu and Syrdarya basins in southern Kazakhstan, all using ISR, plus the Ulba Metallurgical Plant, which makes beryllium, tantalum and niobium products and nuclear fuel pellets. It is majority-owned by the sovereign wealth fund Samruk-Kazyna, with a ~25% free float listed as global depositary receipts (GDRs) in London and shares in Astana. (U₃O₈ = triuranium octoxide, or yellowcake, the concentrate uranium reserves and prices are quoted in; tU = tonnes of uranium metal, the unit the filing reports volumes in — 1 tU ≈ 2,600 lb U₃O₈; Mlb = million pounds; ISR = in-situ recovery, which dissolves uranium in place with sulphuric acid and pumps it to surface; C1 = cash operating cost per pound; AISC = all-in sustaining cost per pound; MET = Mineral Extraction Tax.)
Figure 1. Kazatomprom in numbers
overvalued
Figure data: Kazatomprom 2025 Integrated Annual Report (revenue, cost, production, reserves, balance sheet); market data (GDR price, market capitalisation, ~259.36 m shares) per Investing.com as of the 17 August 2026 LSE close. C1 and AISC are attributable-basis, in US dollars, as reported. Rating per Section 9, NAV per Section 7.
Table 1. Kazatomprom in numbers
| Metric | Value | As of |
|---|---|---|
| GDR price / market capitalisation | US$72.80 / US$16.4 bn | 17 Aug 2026 |
| Enterprise value | ~US$16.2 bn | 17 Aug 2026 |
| Shares in issue | 259,356,608 (unchanged YoY) | 31 Dec 2025 |
| 52-week GDR range | US$42.25 – US$93.00 | 17 Aug 2026 |
| Revenue | KZT 1,803 bn (~US$3.46 bn) | FY2025 |
| Adjusted EBITDA / attributable EBITDA | KZT 1,133 bn / KZT 872 bn (~US$2.17 / 1.67 bn) | FY2025 |
| Net profit (attributable to owners) | KZT 570 bn (~US$1.09 bn) | FY2025 |
| Production — 100% / attributable | 25,839 tU (67.2 Mlb) / 13,519 tU (35.15 Mlb) | FY2025 |
| 2026 production guidance (attributable) | 14,500–15,500 tU (~37.7–40.3 Mlb) | FY2025 report |
| C1 cash cost / AISC (attributable) | US$18.06 / US$29.53 per lb | FY2025 |
| Average realised price — Group / KAP | US$65.32 / US$62.33 per lb | FY2025 |
| Attributable reserves / resources (incl. reserves) | ~735 Mlb / ~1,233 Mlb U₃O₈ | 31 Dec 2025 |
| Net cash / net debt-to-EBITDA | ~US$0.28 bn / −0.12× | 31 Dec 2025 |
| Dividend per share (for 2024) | KZT 1,264 (~US$2.58) · ~3.5% yield | paid Jul 2025 |
| Quality rating / valuation read | 4.2/5 (Solid) / Modestly overvalued | 20 Aug 2026 |
Source: Kazatomprom 2025 Integrated Annual Report for operating, cost, reserve and financial figures (KZT converted to US$ at the 2025 average KZT 521.37/US$ for the income statement, the 31 Dec 2025 close of KZT 502.57/US$ for the balance sheet); reserves and resources on a JORC basis attributable to the Group, effective 31 December 2025; GDR price, share count and market data per Investing.com as of the 17 August 2026 LSE close. Enterprise value = market capitalisation less ~US$0.28 bn of net cash. Listed: Public (LSE: KAP / AIX: KAP); ~75% state-owned via Samruk-Kazyna and the Ministry of Finance. Reserve life ≈ attributable reserves ÷ 2025 attributable production.
Thesis in brief. Bull: there is no cheaper, larger uranium reserve base anywhere. Kazatomprom runs ~23% of world primary supply at a C1 cash cost of US$18.06/lb against a ~US$65/lb realised price, holds ~735 Mlb of attributable reserves for roughly 21 years of life, sits in net cash, is ramping production ~10% in 2026, and pays out most of its free cash flow — a ~3.5% dividend at today’s price. Bear: it is a single-country, state-controlled business whose majority owner sets the dividend, whose margins were just cut by a higher Mineral Extraction Tax, and whose December 2025 Subsoil Code amendments hand the state priority rights over production — so a conservative DCF struck at a Kazakhstan risk premium lands about 25% below the price. What tips it: whether the term uranium price keeps rising fast enough to outrun the tax and the discount, because on today’s deck the assets are worth less than the market pays. Full rating in Section 9.
How to read this analysis: here for the verdict? The statcards above and the rating in Section 9 are the whole story. Want the evidence? Read Section 2 (the assets) through Section 7 (the valuation).
2. Assets & operations
Uranium spent 2026 in an unusual place: the spot price sat near US$86/lb in August, while the long-term contract indicator — the price that matters most to a company selling under multi-year utility contracts — held near US$86–90/lb, the highest since 2008 and up from US$80 a year earlier. That term-over-spot strength is the defining feature of this cycle, and the US$100/lb base deck in Section 7 sits one grid rung above it. For how uranium is priced and why the term market behaves differently from spot, see the Uranium — A Complete Market Guide . This section spends its words on the company.
2.1 Portfolio overview & map
Kazatomprom is the mirror image of a single-mine miner: its production is spread across fourteen ISR operations, none of them individually huge, but together the largest uranium output on the planet. Every operation uses the same low-cost method — sulphuric acid injected through wells to dissolve uranium in porous sandstone, then pumped to surface — and almost every one is a joint venture in which Kazatomprom holds anything from 30% to 100% and is the operator.
Table 2. Uranium mining portfolio, FY2025 (attributable interests)
| Operation | Ownership | Stage | 2025 output (100%, tU) | 2025 output (attrib., tU) | Method | Partner / note |
|---|---|---|---|---|---|---|
| JV KATCO LLP | 49% | Producing | 3,714 | 1,820 | ISR | Orano (France) JV; South Tortkuduk expansion |
| Karatau LLP | 50% | Producing | 3,622 | 1,811 | ISR | Uranium One (Rosatom) partner |
| JV Inkai LLP | 60% | Producing | 3,215 | 1,929 | ISR | Cameco 40%; licence to 2045 |
| JV South Mining Chemical Co. | 30% | Producing | 2,845 | 854 | ISR | Uranium One partner |
| JV Akbastau JSC | 50% | Producing | 2,227 | 1,114 | ISR | Uranium One partner |
| Turanium LLP | 50% | Producing | 2,154 | 1,077 | ISR | — |
| MC Ortalyk LLP | 51% | Producing | 1,789 | 912 | ISR | CGN (China) minority |
| JV Budenovskoye LLP | 51% | Producing (ramping) | 1,210 | 617 | ISR | The flagship growth asset |
| Baiken-U LLP | 52.5% | Producing | 1,203 | 632 | ISR | — |
| Semizbay-U LLP | 51% | Producing | 855 | 436 | ISR | CGN (China) minority |
| RU-6 LLP | 100% | Producing | 833 | 833 | ISR | Wholly owned |
| Kazatomprom-SaUran LLP | 100% | Producing | 821 | 821 | ISR | Wholly owned |
| APPAK LLP | 65% | Producing | 805 | 523 | ISR | — |
| JV Zarechnoye JSC | 49.98% | Producing | 546 | 273 | ISR | Uranium One partner |
| Group total (uranium) | — | — | 25,839 | 13,519 | ISR | 67.2 Mlb / 35.15 Mlb U₃O₈ |
| Ulba Metallurgical Plant | 100% | Producing | — | — | Processing | Be, Ta, Nb, fuel pellets |
Source: Kazatomprom 2025 Integrated Annual Report , production by subsidiary. Attributable output is 100% output × Kazatomprom’s ownership. All uranium operations use in-situ recovery. Listed/operator: all Kazatomprom-operated; JV partners named where a third party holds a material minority (Cameco at Inkai, Orano at KATCO, Rosatom/Uranium One and China’s CGN at several). tU = tonnes of uranium; 1 tU ≈ 2,600 lb U₃O₈.
Concentration works differently here than at a two-mine peer. No single operation is more than ~14% of attributable production, and the top three — Inkai, KATCO and Karatau — together are about 41%. That spread is a genuine risk-diluter at the asset level, but it hides a deeper concentration the map cannot: every pound sits in one country, and almost every operation depends on the same input — sulphuric acid — whose supply is the binding constraint on Kazakh ISR.
The asset map is omitted (rule A13): fourteen ISR wellfields clustered in two southern-Kazakhstan basins read more clearly as Table 2 than as a proportional-symbol map, and this post type builds no map graphic — see §10.1.
2.2 Revenue split — by segment & by asset
Kazatomprom is overwhelmingly a single-commodity company, so the conventional by-metal split collapses to a by-segment one: uranium against everything else.
Figure 2. FY2025 revenue by segment
Figure data: Kazatomprom 2025 Integrated Annual Report . Group U₃O₈ sales were KZT 1,638 bn; the balance is Ulba’s rare-metal products (beryllium, tantalum, niobium), fuel pellets, reactives and other services.
Figure 3. FY2025 uranium production by operation, attributable (Mlb U₃O₈)
Source: Kazatomprom 2025 Integrated Annual Report , attributable production by operation, converted from tU at 1 tU = 2,599.8 lb U₃O₈.
Read together, the two figures make one point: uranium is essentially the whole company (91% of revenue), and no single mine dominates the way Cigar Lake or McArthur River dominates Cameco. The diversification is real — but it is diversification within one country and one mining method.
2.3 JV KATCO — the largest single mine
Kazatomprom’s biggest single source of production is KATCO, a 49% joint venture with France’s Orano that Kazatomprom operates in the Moinkum deposit of the Chu-Sarysu basin. It produced 3,714 tU (100%) in 2025 — up 56% on 2024’s 2,388 tU — as the South Tortkuduk extension (a construction project targeting up to ~4,000 tU/yr of sustaining capacity) ramps up. KATCO is the clearest example of the ISR cost advantage: extraction at these grades costs a fraction of hard-rock mining, and the deposit supports decades of life. The asset-level risk is the JV structure itself — Orano’s 51% means Kazatomprom books only 49% of the output and must run the operation to a partner’s satisfaction — and the same sulphuric-acid dependence that constrains the whole portfolio.
2.4 Karatau & the Rosatom-partnered mines
Karatau LLP (50%, with Russia’s Rosatom via Uranium One) produced 3,622 tU (100%) in 2025 in the Budenovskoye ore field — one of the highest-quality ISR deposits in the country. It is the anchor of a cluster of Rosatom-partnered JVs — Karatau, Akbastau (50%), South Mining Chemical Company (30%) and Zarechnoye (49.98%) — that together account for a large share of attributable output. The strategic sensitivity is obvious and worth stating plainly: a meaningful slice of the world’s largest uranium producer is mined in partnership with the Russian state nuclear champion, at a moment when Western utilities are actively trying to build non-Russian fuel supply. Kazatomprom’s uranium is not Russian, but the corporate plumbing behind some of it runs through Moscow — a point that matters to a Western buyer weighing supply security.
2.5 JV Inkai — the Cameco-partnered flagship
Inkai (60% Kazatomprom / 40% Cameco) is the operation Western investors know best, because it appears in Cameco’s accounts too. It produced 3,215 tU (100%) in 2025 against a 2026 target near 3,900 tU (100%), holds a licence to 2045, and is completing a licence-area expansion in 2026. Inkai matters here as the benchmark: it is the same orebody, the same method and the same jurisdiction Cameco values at a 12% discount rate and a 4% Kazakhstan country premium — which is exactly the premium this analysis applies to all of Kazatomprom, because unlike Cameco’s 40% minority stake, Kazatomprom is Kazakhstan. The asset risk is the one the whole sector shares: sulphuric acid supply, which capped Kazakh output in 2024–2025 and is the reason 2026 guidance is explicitly conditioned on acid availability.
2.6 Budenovskoye & the growth pipeline
The thesis-defining growth asset is JV Budenovskoye LLP (51%), where a dedicated 6,000 tU/yr processing complex is under construction — one of the largest new uranium projects in the world. Budenovskoye produced only 1,210 tU (100%) in 2025 (nearly doubling 2024’s 617 tU) but is designed to become a top-tier contributor as the plant ramps, which is why the 2026 production guidance steps up ~10%. Alongside it sit three more construction and development projects: the South Tortkuduk (Moinkum) extension at KATCO, the Zhalpak surface complex (900 tU/yr) and Inkai Site No. 3 (2025–2030). This pipeline is the reason reserve life and production can rise together rather than trade off.
2.7 Other operations, Ulba & the rare-metals tail
The remaining wholly-owned and majority operations — RU-6, Kazatomprom-SaUran, APPAK, MC Ortalyk, Baiken-U, Semizbay-U — are each smaller ISR mines that together add roughly a third of attributable output and are named in Table 2. Separately, the Ulba Metallurgical Plant (100%) is a genuinely different business: it produces beryllium (723 t), tantalum (108 t) and niobium (20 t) products plus nuclear fuel pellets (257 t), and it is expanding its rare-metals base with new exploration licences in the Karaganda region. Ulba is small — under 10% of revenue — but it is the one part of Kazatomprom that is not a pure uranium play, and it is valued separately in Section 7.
2.8 Production, reserves & costs
Table 3. Group uranium production, reserves and cost, FY2023–FY2025
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Production, attributable (Mlb U₃O₈) | 29.0 | 31.9 | 35.15 |
| Production, 100% basis (Mlb U₃O₈) | — | 60.5 | 67.2 |
| C1 cash cost, attributable (US$/lb) | — | 16.59 | 18.06 |
| AISC, attributable (US$/lb) | — | 27.65 | 29.53 |
| Average realised price — Group (US$/lb) | — | 69.48 | 65.32 |
| Attributable reserves (Mlb U₃O₈) | — | — | ~735 |
Source: Kazatomprom 2025 Integrated Annual Report ; attributable production converted from 11,169 tU (2023), 12,286 tU (2024) and 13,519 tU (2025) at 1 tU = 2,599.8 lb U₃O₈. Reserves are JORC proven-and-probable attributable to the Group, effective 31 December 2025. Dashes mark figures not disclosed on a consistent basis in the current filing.
Figure 4. Attributable uranium production, FY2023–FY2025
Figure data: Table 3.
Three facts define the group profile. Cost: the 2025 attributable C1 cash cost of US$18.06/lb is the lowest of any producer of scale in the world — roughly a third of Paladin’s and comfortably below Cameco’s mine-gate cash cost — but it rose 9% year over year, driven mainly by the higher Mineral Extraction Tax rate, and 2026 C1 guidance of US$23.50–25.00/lb is a step-change higher still. Longevity: ~735 Mlb of attributable reserves against ~35 Mlb/yr of production is roughly 21 years of reserve life, with a further ~500 Mlb of attributable resource behind it (~1,233 Mlb of total attributable resource including reserves). Growth: production has risen every year since 2023 and is guided up ~10% again in 2026, the rare combination of a rising output profile and a two-decade reserve life. The one thing to watch is that the cost advantage, while enormous, is narrowing as Kazakhstan raises the tax it takes from the sector.
2.9 Peer positioning
The peer set used throughout this analysis is the listed uranium producers and near-producers with published production, cost and reserve figures — the only group against which Kazatomprom’s scale and cost compare like for like. Orano and Rosatom are state-owned and unlisted, and are excluded for that reason.
Table 4. Peer quality comparison
| Company | Listing | 2026 attributable production (Mlb) | Unit cost | Attributable reserves/resources (Mlb) | Concentration |
|---|---|---|---|---|---|
| Kazatomprom | Public (LSE: KAP) | 37.7–40.3 | US$18.06/lb C1; US$29.53/lb AISC (2025) | ~735 (P&P) | 14 ISR ops, one country |
| Cameco | Public (NYSE: CCJ / TSX: CCO) | 19.5–21.5 | C$23.74/lb produced (~US$17); C$55.39 blended | 433.0 (P&P) | Top two assets 78% of reserves |
| Paladin Energy | Public (ASX: PDN) | 5.1–5.6 (FY2027) | US$44–48/lb cost of production (FY2027) | not disclosed comparably | Langer Heinrich + PLS |
| Uranium Energy | Public (NYSE American: UEC) | ramping (~1–3) | not yet at steady state | ~308 (M&I + inferred; no reserves) | US ISR + Canadian resources |
| NexGen Energy | Public (TSX: NXE) | nil — Rook I in construction | C$13.86/lb LOM all-in (FS estimate) | 239.6 (probable, 100%) | Single asset |
Source: Kazatomprom 2025 Integrated Annual Report ; Cameco figures per the Metal Pilot Cameco analysis ; Paladin Energy quarterly report to 30 June 2026 ; Uranium Energy FY2025 Form 10-K ; NexGen Rook I feasibility study . Cost bases are not identical — Kazatomprom quotes an attributable C1/AISC, Cameco a produced cash cost, Paladin a cost of production, NexGen an all-in study estimate — so the column ranks approximately, not exactly.
Kazatomprom sits first in the set on both scale and cost — it produces nearly twice Cameco’s attributable pounds at roughly the same or lower unit cash cost, and it does so from a reserve base of ~735 Mlb, larger than any listed peer’s. What it lacks relative to Cameco is jurisdictional quality (one emerging-market country versus tier-one Saskatchewan) and the governance of a widely-held company (a state majority owner rather than a dispersed float). To rank all five on reserves, grade, cost and production, screen the sector on Metal Pilot.
3. Financials & balance sheet
Kazatomprom’s financial profile is unusual for a resource company: enormous margins, a net-cash balance sheet, and a payout policy that returns most of the cash — but all of it reported in a volatile emerging-market currency and steered by a state majority owner.
Table 5. Financial summary, FY2024–FY2025 (KZT bn unless stated)
| Metric | FY2024 | FY2025 |
|---|---|---|
| Revenue | 1,813 | 1,803 |
| Revenue YoY % | — | −1% |
| Net profit — total / attributable to owners | 1,132 / 872 | 807 / 570 |
| Adjusted attributable net profit (ex one-time) | 577 | 570 |
| EPS attributable (KZT/share) | 3,363 | 2,200 |
| Adjusted EBITDA | 1,097 | 1,133 |
| Attributable EBITDA | 789 | 872 |
| Net cash | 144 | 140 |
| Net debt / adjusted EBITDA | −0.13× | −0.12× |
| Dividend paid in year (KZT bn) | 315 | 328 |
Source: Kazatomprom 2025 Integrated Annual Report , income statement, balance sheet and dividend history (the filing presents FY2024 and FY2025 on a consistent basis; earlier years are not carried here rather than mixed across restated bases). Figures are in Kazakhstani tenge; at the 2025 average of KZT 521.37/US$, 2025 revenue is ~US$3.46 bn and attributable net profit ~US$1.09 bn. Revenue was essentially flat (−1%) year over year; the drop in total and attributable net profit is an accounting artefact — 2024 carried a KZT 296 bn one-time gain from a business combination, and adjusted attributable net profit was flat at KZT 570–577 bn. “Dividend paid in year” is the cash paid to shareholders during each year (KZT 328 bn in 2025 was the dividend for 2024).
Figure 5. Attributable EBITDA by fiscal year, FY2024–FY2025 (KZT bn)
Figure data: Table 5. Attributable EBITDA — the cleanest read of the uranium business’s cash earnings — rose 11% even as revenue was flat, because the JV-and-associate mix strengthened; revenue and the headline net-profit line are read from Table 5 rather than overlaid (rule A13). The revenue-history chart is not shown because the current filing presents only two comparative years — see §10.1.
Reading the three statements. Applying the framework in the Financial Metrics for Commodity Investing guide (/guides/commodity-financial-metrics/ ) to one company: the income statement is genuinely high-margin — a ~US$65/lb realised price on an ~US$18/lb cash cost is a spread few miners of any commodity can match — but the 2025 net-profit decline is an accounting artefact, not a warning: 2024 carried a large one-off revaluation gain, and adjusted net profit was roughly flat. The cash flow backs the earnings: the dividend (KZT 328 bn for 2024) is funded from operating cash, not new debt. The balance sheet is the standout — net cash of ~US$0.28 bn and net debt-to-adjusted-EBITDA of −0.12×, against management’s stated ceiling of 1.0×. The one red flag is not in the numbers but around them: the reporting currency swings (a KZT 33 bn foreign-exchange loss ran through 2025 earnings), and the effective tax take is rising as the MET climbs.
Capital returns. Kazatomprom’s dividend policy is tied to attributable free cash flow, and in practice it pays out a large share of it: KZT 328 bn for 2024 (KZT 1,264/share, ~US$2.58), paid July 2025 — a ~3.5% trailing yield at today’s GDR price, far above Cameco’s nominal 0.17%. The catch is control: the majority owner, Samruk-Kazyna, effectively sets the payout, so the dividend is a policy of the state, not a board answerable to the float. There are no buybacks, and the share count is fixed at 259,356,608. The hedge posture is straightforward — Kazatomprom is effectively unhedged on the uranium price, selling under a contract book with spot-referenced pricing, and carries no material commodity hedge book; its main financial exposure is the KZT/US$ rate, since costs are largely in tenge and sales in dollars.
4. Management, strategy & corporate structure
4.1 Management & governance
Meirzhan Yussupov is Chairman of the Management Board (chief executive), leading the company through its 2025 production ramp and the launch of the 2025–2034 Strategy; Arman Argingazin chairs the Board of Directors. The governance reality is the one fact that shapes every other: Kazatomprom is a controlled company. Its majority owner is the sovereign wealth fund Samruk-Kazyna, and the board and strategy answer to the state. The board carries independent directors and the company has steadily improved its disclosure since the 2018 London listing — the Integrated Annual Report is a genuinely detailed document — but a minority GDR holder has no ability to change control, and related-party dealings (JVs with Rosatom’s Uranium One and China’s CGN, sales through state-linked channels) are a structural feature, not an exception. This is scored, not merely noted, in Section 9.
4.2 Strategy & capital allocation
The stated strategy, formalised in the 2025–2034 Strategy launched in 2025, is to hold Kazatomprom’s position as the lowest-cost, largest primary producer while expanding the resource base and diversifying sales markets. The evidence is concrete: production guided up ~10% in 2026; new supply contracts signed in 2025 with utilities in Switzerland, the Czech Republic and Japan; deliveries to 21 customers in 8 countries; and exploration launched at two new Turkestan-region sites with a stated intent to ramp exploration spending. Capital allocation runs on a market-discipline principle — Kazatomprom has historically flexed production to demand rather than flooding the market — alongside the FCF-linked dividend. The forward target that matters is the 2026 revenue guidance of KZT 2,200–2,300 bn (well above 2025’s KZT 1,803 bn), driven by higher volumes and a stronger tenge-to-dollar translation.
4.3 Ownership & corporate structure
The ownership structure is the thesis in one line: as of 31 December 2025, Samruk-Kazyna held ~62.99% and the Ministry of Finance ~12.01% — roughly 75% state — with the remaining ~25% free-floated as ordinary shares (AIX) and GDRs (LSE, one GDR per share). The corporate structure beneath it is a web of joint ventures, each named in Table 2: Cameco at Inkai (40%), Orano at KATCO (51%), Rosatom/Uranium One at Karatau, Akbastau, SMCC and Zarechnoye, and China’s CGN at MC Ortalyk and Semizbay-U. These partnerships are how Kazatomprom shares capital and offtake, and they are also why attributable production (13,519 tU) is barely half of 100%-basis production (25,839 tU). There are no material warrants and no convertible debt; the 259.4 million share count is stable.
5. ESG & sustainability
Kazatomprom’s environmental profile is genuinely better than conventional uranium mining on the metric that matters most: ISR leaves no waste rock, no tailings dam and a far smaller surface footprint than open-pit or underground mining, because the uranium is dissolved in place. The company reports greenhouse-gas emissions, has a stated decarbonisation direction, and its 2025 report is aligned with recognised disclosure frameworks. Against that sit two real issues. The first is sulphuric acid — the reagent that makes ISR cheap is also its largest environmental and supply-chain exposure, and its availability is the binding operational constraint. The second is groundwater: ISR mobilises uranium and associated elements in aquifers, and restoration of groundwater to baseline is a long-dated obligation that the disclosure treats but that a reader should weight. Socially, Kazatomprom is one of Kazakhstan’s largest employers and taxpayers, and the higher MET is partly framed by the state as capturing more of the resource’s value for the country — a reminder that the “S” and the fiscal risk are the same coin. On balance the ESG profile is adequate and improving, held back by the groundwater and acid exposures and by state-controlled disclosure incentives.
6. Risks
Table 6. Risk register
| Risk | Type | Likelihood / impact | What is exposed | Mitigant |
|---|---|---|---|---|
| Rising Mineral Extraction Tax | Jurisdiction / fiscal | High / High | The C1 cost advantage; 2026 C1 guided to US$23.50–25.00/lb | Cost still far below peers; production growth absorbs some tax |
| Subsoil Code — state priority rights | Jurisdiction | Medium / High | Control and transferability of production rights | Existing agreements grandfathered; state is also the owner |
| Sulphuric acid supply | Operational | High / Medium | 2026 output — guidance is explicitly acid-conditioned | New domestic acid capacity; inventory management |
| State control / minority governance | Governance | High / Medium | Dividend policy, related-party JVs, capital allocation | FCF-linked policy; improving disclosure; LSE listing |
| Uranium term-price reversion | Commodity | Medium / High | ~20,000 tU/yr of sales repricing through the contract book | Market-discipline supply policy; low cost floor |
| KZT/US$ volatility | Financial | High / Low–Medium | Reported earnings and dividends (costs KZT, sales US$) | Natural hedge on costs; no debt |
| Rosatom-partnered JVs & sanctions optics | Geopolitical | Medium / Medium | Karatau, Akbastau, SMCC, Zarechnoye output & Western appetite | Uranium itself is non-Russian; diversified customer base |
| Groundwater restoration liabilities | ESG | Low / Medium | Long-dated aquifer-restoration obligations | ISR’s smaller footprint; provisioned over decades |
Source: Kazatomprom 2025 Integrated Annual Report , risk factors and the tax and Subsoil Code discussions. Likelihood and impact are this analysis’s assessment, not the company’s.
Figure 6. Risk matrix — likelihood against impact
Source: Table 6. Shaded region marks the high-likelihood, high-impact quadrant.
Two risks deserve more than a table row. The first is the tax-and-control creep. The higher MET already lifted 2026 C1 guidance by ~US$6/lb, and the December 2025 Subsoil Code amendments — granting Kazatomprom (i.e. the state) priority rights and restricting transfers of production rights — point the same direction: the government intends to capture more of the resource’s value. Existing agreements are grandfathered, but the trend is the single biggest threat to the cost advantage that is the entire bull case, and it is why the valuation applies a Kazakhstan risk premium to the whole company rather than to one asset. The second is the sulphuric-acid ceiling, which is not a probability but a physical constraint: 2026 production guidance is explicitly conditioned on acid availability, and it was acid, not orebody, that capped Kazakh output in 2024–2025.
7. Valuation
Valuation as of 20 August 2026, in US dollars. Horizon: reserve-life NAV. Price deck (Table 3b uranium rungs): bear US$75/lb, base US$100/lb, bull US$125/lb; the term contract indicator (~US$86–90/lb) and spot (~US$86/lb) sit just below the US$100 base rung and carry as cross-checks. Discount rate 12% (an ~8–9% uranium-producer base plus a ~3–4% Kazakhstan country premium — the same premium Cameco applies to its Kazakh Inkai stake, extended to the whole company because Kazatomprom is Kazakhstan). Share basis 259.36 m shares (no material dilution). Market data as of the 17 August 2026 LSE close (US$72.80/GDR, US$16.4 bn market capitalisation).
Kazatomprom is a producer/operator (mining), so the anchor is a reserve-life net-asset-value DCF on the attributable production stream, complemented by an EV/EBITDA multiple and an FCF-yield support, each converted to a value per share. The conclusion: a blended base-case fair value of US$54.50 per share, inside a US$36–78 range, against a US$72.80 GDR price — an implied −25%. The value read is Modestly overvalued. The NAV alone is ~US$53.60 (a ~1.36× P/NAV); the two cash-flow methods bracket it, and all three sit below the price because the market pays a premium for the scale, the dividend and the leverage to a rising term price that a conservative Kazakh-discounted DCF does not carry.
7.1 Method selection
Kazatomprom is valued on the standard producer/mining set, held at the default weights. The NAV/DCF is the anchor because it is the only method that prices the reserve life and the ramping production profile directly; EV/EBITDA and FCF-yield check it against how the market pays for cash flow and distributions. No transaction-comparable method carries weight — there is no arm’s-length sale of a state-controlled national uranium champion to reference.
Table 7. Valuation method selection and weights
| Method (each emits a value per share) | Why it applies to this archetype | Weight |
|---|---|---|
| NAV / DCF at target P/NAV (primary intrinsic) | The only method that values the 21-year reserve life and the ramping production stream on their own economics; taken to an equity NAV per share (7.2) | 50% |
| EV/EBITDA at peer-relevant multiple | A group multiple on attributable EBITDA, bridged to equity — the standard producer relative check (7.3) | 30% |
| FCF-yield / dividend-yield support | Kazatomprom pays out most of its free cash flow, so a target FCF/dividend yield is a genuine value anchor here (7.3) | 20% |
| Cross-checks, 0% weight (7.4): EV per annual/reserve pound vs. peers, analyst read | Unweighted — they test the blend, they do not enter it (rule V12) | 0% |
Source: this analysis; method map per the Metal Pilot valuation framework (producer/mining row), held at the 50/30/20 default. Weights sit inside the input-family caps (rule V18: intrinsic 50% single-method; the two cash-flow methods 50% together).
7.2 Net asset value
The NAV models the attributable production stream at the US$100/lb base deck, net of a realisation discount (Kazatomprom’s realised price runs below spot because of contract structure and sales through trading channels), an AISC rising from ~US$30 toward ~US$34/lb as the MET climbs, the Kazakh tax and royalty regime, and a 12% discount rate.
- Attributable uranium production — ~39 Mlb/yr at maturity over ~21 years to reserve exhaustion, realised at ~US$88/lb on the base deck, AISC ~US$32/lb, after MET and ~20% corporate tax → ~US$11.5 bn.
- Resource-extension tail — ~500 Mlb of attributable resource beyond reserves, produced in the out-years and discounting to little, carried at a conservative ~US$1.5 bn.
- Ulba Metallurgical (rare metals & fuel pellets) — ~US$0.6 bn on a modest EBITDA multiple for a small, licence-protected processing business.
- Net cash — +US$0.28 bn at 31 December 2025.
Figure 7. NAV build-up to equity value (US$ bn)
mining
tail
cash
NAV
Figure data: this analysis’ NAV model, built on the Kazatomprom 2025 Integrated Annual Report (attributable production, reserves, C1/AISC, guidance) at the US$100/lb base deck and a 12% discount rate. Equity NAV US$13.88 bn ÷ 259.36 m shares = ~US$53.60/share.
Figure 8. NAV per share sensitivity — long-term uranium price × discount rate
| Long-term uranium price | ||||||
|---|---|---|---|---|---|---|
| US$50 | BearUS$75 | BaseUS$100 | BullUS$125 | US$150 | ||
| Discount rate | 10% | US$33 | US$46 | US$59 | US$77 | US$96 |
| 12% (base) | US$29 | US$41 | US$53.60 | US$70 | US$88 | |
| 14% | US$26 | US$37 | US$48 | US$63 | US$80 | |
Figure data: this analysis’ NAV model. Price columns: the fixed uranium grid (US$50–US$150 by US$25; Table 3b of the valuation playbook). Base case: US$100/lb long-term uranium (the nearest grid rung above the ~US$86–90/lb term price), 12% discount rate.
A US$25 rung on the uranium price moves NAV/share by roughly US$12–15 — meaningful operating leverage, tempered by the Kazakh profit-based taxes that take a rising share of each incremental dollar. Only the top-right of the grid — uranium near US$150/lb — carries the NAV clearly above the US$72.80 price.
7.3 Relative valuation
The two relative methods each convert to a value per share (rule V11).
Table 8. Relative valuation — implied value per share (base case)
| Weighted method | Subject metric (base) | Target multiple / yield | Implied equity | Value/share |
|---|---|---|---|---|
| EV/EBITDA | Attributable EBITDA ~US$2.1 bn (FY2026e) | 6.5× (uranium producer, Kazakh/state discount) | EV US$13.65 bn + US$0.28 bn net cash = US$13.93 bn | US$53.70 |
| FCF / dividend-yield support | Attributable FCF ~US$1.2 bn | 8.0% target FCF yield | US$15.0 bn equity | US$57.80 |
Source: author’s calculations. Target multiples: the 6.5× EV/EBITDA sits well below Cameco’s ~30× traded multiple and toward the low end of a producer 4–10× band, reflecting single-country jurisdiction, state control and the minority-governance discount; the 8.0% target FCF yield is generous for a payout-heavy name and consistent with the ~3.5% dividend yield plus retained cash. FY2026e attributable EBITDA of ~US$2.1 bn reflects the ~10% production step-up and the KZT 2,200–2,300 bn revenue guidance — estimates, not company guidance to EBITDA.
Both methods land close to the NAV — US$53.70 and US$57.80 — and all three sit below the US$72.80 price. On the market’s own multiples, Kazatomprom trades at roughly ~7.8× forward attributable EBITDA and ~17× earnings; cheap against Cameco, but the appropriate multiple for a state-controlled, single-country producer is lower still, which is why even the generous decks here fall short of the price.
7.4 Cross-checks
These carry no weight in the blend (rule V12).
Peer diagnostics (unweighted). On ~US$16.2 bn of enterprise value, Kazatomprom trades at about US$430 per annual pound of attributable production and ~US$22 per pound of attributable reserves — far cheaper than Cameco’s ~US$2,100/annual pound and ~US$100/reserve pound (Cameco analysis, §7.4). Kazatomprom is, unambiguously, the cheapest large uranium producer on pounds-in-the-ground. The question this analysis answers is whether “cheaper than the most expensive name in the sector” is the same as “cheap in absolute terms” — and on a DCF struck at a Kazakh risk premium, it is not.
Analyst read (0% weight). Sell-side coverage of the GDR is thinner than for the US-listed peers and skews positive on the uranium-price thesis; it values the scale and the term-price leverage rather than a Kazakh-discounted DCF, which is the same gap this analysis measures.
7.5 Scenario analysis
Every weighted method is recomputed in three coherent worlds — each uranium deck a rung of the fixed grid (rule V26).
Table 9. Scenario assumptions and per-method value per share
| Scenario | Uranium deck | Discount | Key assumptions | M1 NAV | M2 EV/EBITDA | M3 FCF-yield |
|---|---|---|---|---|---|---|
| Bear | US$75/lb | 14% | Realised ~US$70/lb; AISC rising toward US$36/lb on higher MET; EBITDA ~US$1.6 bn at 5.5×; FCF ~US$0.9 bn at 10% | US$37 | US$34 | US$35 |
| Base | US$100/lb | 12% | Realised ~US$88/lb; AISC ~US$32/lb; EBITDA ~US$2.1 bn at 6.5×; FCF ~US$1.2 bn at 8% | US$53.60 | US$53.70 | US$57.80 |
| Bull | US$125/lb | 11% | Realised ~US$112/lb; AISC ~US$32/lb; EBITDA ~US$2.6 bn at 7.5×; FCF ~US$1.6 bn at 7% | US$74 | US$76 | US$88 |
Source: this analysis’ model, per the methods in 7.2–7.3 with the stated assumption changes. Illustrative scenarios, not forecasts. The three decks are the US$75 / US$100 / US$125 rungs of the fixed uranium grid. The bear case embeds the MET and Subsoil-Code fiscal risks from Table 6; the bull case embeds the production ramp in Section 8.
7.6 Fair value & conclusion
Each weighted method’s value per share is multiplied by its weight and summed to a blended fair value — once per scenario.
Table 10. Fair-value blend
| Method | Weight | Bear value/sh | Base value/sh | Bull value/sh | Base contribution |
|---|---|---|---|---|---|
| NAV / DCF | 50% | US$37 | US$53.60 | US$74 | US$26.80 |
| EV/EBITDA at 6.5× | 30% | US$34 | US$53.70 | US$76 | US$16.11 |
| FCF-yield at 8% | 20% | US$35 | US$57.80 | US$88 | US$11.56 |
| Blended fair value per share | 100% | US$36 | US$54.50 | US$78 | = US$54.47 |
| Current GDR price (17 Aug 2026) | US$72.80 | ||||
| Implied return vs. base case | −25% |
Source: this analysis; weights per Section 7.1 at the 50/30/20 producer default. Horizon: reserve-life NAV. Cross-checks carried at 0% weight and discussed in 7.4. Base blend = 0.50 × US$53.60 + 0.30 × US$53.70 + 0.20 × US$57.80 = US$54.47.
Figure 9. Value per share by method and scenario
| Scenario | |||
|---|---|---|---|
| BearUS$75 | BaseUS$100 | BullUS$125 | |
| NAV / DCF (50%) | US$37 | US$53.60 | US$74 |
| EV/EBITDA (30%) | US$34 | US$53.70 | US$76 |
| FCF-yield (20%) | US$35 | US$57.80 | US$88 |
| Blended fair value | US$36 | US$54.50 | US$78 |
Figure data: Table 10. Shading ranks every cell within this figure’s own US$34–US$88 range; the base-case blend carries the outline. Current GDR price US$72.80 (17 Aug 2026). The bull case — uranium at US$125/lb — is the one column that carries the blend above the price.
Conclusion. The blended fair value is US$54.50 in the base case, inside a US$36–US$78 bear-to-bull range, against a US$72.80 GDR price — an implied −25%. The value read is Modestly overvalued: only the bull case (uranium at US$125/lb) lifts the blend above the price. The three methods agree tightly at ~US$54–58 because Kazatomprom’s economics are transparent — a known reserve life, a known cost, a known payout — and the gap to the price is not a modelling artefact but a premium the market pays for the scale, the dividend and the term-price torque that a Kazakh-discounted DCF will not carry. Note the contrast with Cameco (−65%, Overvalued): Kazatomprom is far cheaper on every per-pound and cash-flow measure — it is the value name of the sector — but “cheapest of an expensive group” still lands modestly above a conservative fair value here. To run the same reserve, cost and production screen across every listed uranium name, use Metal Pilot.
Assumptions box. Valuation date 20 August 2026; market data as of the 17 August 2026 LSE close (US$72.80/GDR, 259.36 m shares, US$16.4 bn market capitalisation, ~US$0.28 bn net cash). Trading currency US dollars (the GDR trades in US$); Kazatomprom reports in KZT, converted at the 2025 average KZT 521.37/US$ (income statement) and the 31 Dec 2025 close of KZT 502.57/US$ (balance sheet). Price decks (Table 3b uranium rungs): bear US$75/lb, base US$100/lb, bull US$125/lb, held flat in real terms; term indicator ~US$86–90/lb. Discount rate 12% (uranium-producer base + Kazakhstan country premium), sensitised 10–14%. Method weights 50/30/20 (NAV / EV·EBITDA / FCF-yield), the producer default. Reserves, production, cost and guidance from the 2025 Integrated Annual Report ; forward EBITDA and FCF are author estimates. Cross-checks (0% weight): EV/annual pound, EV/reserve pound, analyst read.
8. Near-term catalysts (1–3 years)
Table 11. Near-term catalysts
| Catalyst | Expected timing | Why it benefits Kazatomprom |
|---|---|---|
| 2026 production ramp (+~10%) | Through 2026 | Attributable output guided to 14,500–15,500 tU (~37.7–40.3 Mlb) — more pounds sold into a strong term market |
| Budenovskoye 6,000 tU/yr plant | Ramping 2026–2028 | The single largest new uranium project; lifts low-cost production and extends the growth runway |
| South Tortkuduk (KATCO) extension | Ramping | Sustains up to ~4,000 tU/yr at the largest single mine |
| Term uranium price above US$86–90/lb | Ongoing | Realised prices reset upward through the contract book as legacy contracts roll |
| New utility supply contracts | Signed 2025; deliveries phased | Switzerland, Czech Republic, Japan contracts diversify the customer base beyond China and Russia |
| Inkai licence-area expansion | 2026 | Extends reserves at the Cameco-partnered flagship |
| FY2025 dividend declaration | 2026 | Payout tied to attributable free cash flow; a higher uranium price lifts the distribution |
Source: Kazatomprom 2025 Integrated Annual Report ; 2026 guidance and strategy sections. Timing reflects company guidance and is not a guarantee.
These are mostly already-contracted or under-construction rather than speculative, and they cluster on one theme: more low-cost pounds into a rising term market. The swing factor is not the orebody — reserves and life are ample — but sulphuric acid and the tax regime: the ramp delivers only if acid is available and the MET does not climb faster than the price.
9. Rating & verdict
Table 12. Scorecard rationale
| Dimension | Weight | Score | Rationale |
|---|---|---|---|
| 1. Asset quality & scale | 15% | ★★★★★ | The world’s largest uranium producer (~23% of global primary supply, 35.15 Mlb attributable), 14 diversified ISR operations, and the sector’s lowest extraction cost; no listed peer matches the scale (2025 IAR; peer set §2.9). |
| 2. Cost position & margins | 15% | ★★★★★ | C1 cash cost of US$18.06/lb is the lowest of any producer of scale — roughly a third of Paladin’s and below Cameco’s mine-gate cost — on a ~US$65/lb realised price. The deduction the stars can’t show: a rising MET lifted 2026 C1 guidance to US$23.50–25.00/lb (2025 IAR). |
| 3. Reserves, life & replacement | 15% | ★★★★★ | ~735 Mlb of attributable P&P reserves (~21 years at current output), with ~500 Mlb of additional attributable resource behind it and production still rising — a longevity-and-growth combination no listed peer has (2025 IAR, JORC, 31 Dec 2025). |
| 5. Balance sheet & liquidity | 15% | ★★★★★ | Net cash of ~US$0.28 bn and net debt/adjusted EBITDA of −0.12× against a self-imposed 1.0× ceiling; a payout-heavy but self-funding structure. Best-capitalised in the peer set alongside Cameco (2025 IAR). |
| 6. Capital allocation & returns | 15% | ★★★☆☆ | A ~3.5% FCF-linked dividend (KZT 328 bn for 2024) and disciplined, demand-matched supply. Against that: the payout is effectively set by the state majority owner, there are no buybacks, and a rising MET is quietly redirecting cash to the government (2025 IAR). |
| 4. Growth & optionality | 6.25% | ★★★★☆ | 2026 production guided up ~10%; the Budenovskoye 6,000 tU/yr plant, South Tortkuduk, Zhalpak and Inkai Site 3 all under construction; exploration launched at two new sites — a rare rising-output profile on a 21-year base (2025 IAR). |
| 7. Management & governance | 6.25% | ★★★☆☆ | Competent operational leadership (Yussupov, Argingazin) and improving disclosure since the 2018 LSE listing, but a ~75% state owner controls the board, the dividend and capital allocation, and related-party JVs (Rosatom, CGN) are structural — a genuine minority-governance discount (2025 IAR). |
| 8. Jurisdiction & geopolitics | 6.25% | ★★☆☆☆ | 100% of production in one emerging-market country, with a rising MET, December 2025 Subsoil Code amendments granting state priority rights, and Rosatom-partnered JVs that complicate the Western supply-security story — the weakest dimension, and the reason for the whole-company risk premium (2025 IAR). |
| 9. ESG & licence to operate | 6.25% | ★★★☆☆ | ISR carries no tailings dam and a small surface footprint — structurally cleaner mining — but sulphuric-acid dependence and long-dated groundwater-restoration obligations are real, and disclosure incentives sit with a state owner (2025 IAR). |
| Composite | 100% | ★★★★ | Solid |
Source: as cited per row — principally the Kazatomprom 2025 Integrated Annual Report . Every score is relative to the peer set declared in §2.9.
The arithmetic: 0.75 + 0.75 + 0.75 + 0.75 + 0.45 + 0.25 + 0.1875 + 0.125 + 0.1875 = 4.20/5 → ★★★★, Solid. Weights follow the producer convention — asset quality, cost, reserves, balance sheet and capital allocation at 15% each — with growth, management, jurisdiction and ESG at 6.25% each. The score is a study in contrast: five-star operations pulled down to Solid by a two-star jurisdiction and a three-star governance structure that are inseparable from being a state-owned national champion.
The two-axis verdict: Solid (★★★★), Modestly overvalued as of 20 August 2026 → “priced about right, edge is the catalyst — the market already pays for the scale and the dividend; the discount to a conservative DCF is the Kazakh risk premium.”
The bull case is that this is the best pure operating business in uranium — the largest, the lowest-cost, net cash, paying a real dividend, and still growing — and that a reader who wants uranium exposure at a fraction of Cameco’s multiple can reasonably argue the market is right to look through the jurisdiction. The bear case is that the jurisdiction is the investment: a single-country, state-controlled producer whose owner sets the payout and whose government is actively raising the tax it takes and tightening its control of the resource, and on a DCF struck at the risk premium that structure deserves, the shares sit about 25% rich. What tips it is the term uranium price — at US$125/lb the assets are worth more than the price; at US$75/lb they are worth half of it — and the fiscal trend, which is moving the wrong way. The Section 8 catalysts move the value axis; none moves the jurisdiction that caps the quality axis, which is why the two are scored separately. To rank Kazatomprom against every peer on these same nine dimensions, screen the sector on Metal Pilot.
10. Sources, methodology & disclaimer
10.1 Sources, methodology & data vintage
Company filings. Kazatomprom 2025 Integrated Annual Report and consolidated financial statements (year ended 31 December 2025) — the spine of this analysis, supplying production by operation, attributable and 100%-basis volumes, C1/AISC, realised prices, the income statement and balance sheet, reserves and resources (JORC, effective 31 December 2025), the dividend, ownership structure, the 2025–2034 Strategy, risk factors, tax and Subsoil Code discussion, and 2026 guidance; prior-year annual reports for 2021–2022 revenue, net profit and EPS. Regulator/exchange record: London Stock Exchange and the Astana International Exchange.
Peer and market data. Metal Pilot Cameco analysis ; Paladin Energy quarterly report to 30 June 2026 ; Uranium Energy FY2025 Form 10-K ; NexGen Energy ; GDR price, share count and market data per Investing.com as of the 17 August 2026 LSE close; uranium spot and term price indicators per published August 2026 market data; FX per the National Bank of Kazakhstan (2025 average KZT 521.37/US$, year-end KZT 502.57/US$, current ~KZT 477/US$).
Methodology. Fundamentals are from the FY2025 filing unless stated; KZT figures are converted to US$ at the rates above. The nine-dimension scorecard uses the producer/mining weighting set out in Section 9, scored against the peer set declared in §2.9; the valuation blends three methods that each emit a value per share — a reserve-life NAV/DCF (50%), an EV/EBITDA (30%) and an FCF-yield support (20%), reproducible from Tables 7–10 and the assumptions box. Reserves and resources are converted from tU at 1 tU = 2,599.8 lb U₃O₈. Two items from the standard set are adapted or omitted: the asset map is omitted (fourteen clustered ISR wellfields read more clearly as Table 2, and this post type builds no map); and the multi-year revenue-history chart is omitted because the current filing presents only two comparative years (FY2024–FY2025) — the financial-summary figure (Figure 5) therefore shows the two-year attributable-EBITDA comparison, and the three-year production history is carried in Figure 4.
Data as of 20 August 2026, market data as of the 17 August 2026 close. Update cadence: refreshed on each annual report and on material events — a change to 2026 production guidance, a further MET or Subsoil Code change, or the FY2025 dividend declaration would each trigger a re-run. Provenance: NAC Kazatomprom JSC — Integrated Annual Report — 2025.
10.2 Disclaimer & disclosure
This analysis is for informational purposes only and is not investment advice. It is a point-in-time snapshot as of 20 August 2026: the GDR price, market capitalisation, valuation multiples, net asset value and the two-axis verdict all move with the market, the uranium price and the KZT/US$ rate. Reserve, resource and production figures are estimates under the JORC Code and may be revised; the valuation is a model built on stated assumptions, not a measurement, and the Kazakhstan discount rate is a judgment a reader may reasonably set higher or lower. The quality rating and value read are analytical judgments, not a recommendation to buy or sell — do your own research and consider a licensed adviser before acting. This report was prepared with AI assistance; figures were sourced from primary filings and reviewed, but verify anything material before acting on it. The author holds no position in any company named here.